68Ga-BCMA PET/CT in Multiple Myeloma

Clinical trial NCT07319897 · RECRUITING

Trial details

NCT number: NCT07319897
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma Multiple Myeloma and Malignant Plasma Cell Neoplasms Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2025-12-25
Primary completion: 2027-12-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.